Comparing the efficacy of two natural surfactants, Curosurf and Alveofact, In treatment of respiratory distress syndrome in preterm infants

International Journal of Women's Health and Reproduction Sciences

Volumn 2, Issue 4, 2014, Pages 245-248

  Gharehbaghi, Manizheh Mostafa ^a   Yasrebi, Sanaz ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alveofact; Curosurf; Preterm Infants; Respiratory Distress Syndrome; Surfactant

Indexed keywords

BERACTANT; PORACTANT;

ARTICLE; BRAIN HEMORRHAGE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFICACY; ECHOCARDIOGRAPHY; FEMALE; HOSPITALIZATION; HUMAN; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; RETROLENTAL FIBROPLASIA; SEPSIS; SUBSTITUTION THERAPY; VENTILATOR;

EID: 84969264257     PISSN: None     EISSN: 23304456     Source Type: Journal    
DOI: 10.15296/ijwhr.2014.36     Document Type: Article

References (20)

1. Burri PH. Fetal and postnatal development of the lung. Ann Rev Physiol 1984; 46:617-28.
2. Engle WA. American Academy of Pediatrics Committee on fetus and newborns. Surfactant replacement therapy for respiratory distress syndrome in preterm and term neonate. Pediatrics 2008; 121: 419-32.
3. Ma CC, Ma S. The role of surfactant in respiratory distress syndrome. Open Respir Med J 2012; 6: 44-53.
4. Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet 1980; 12: 55-9.
5. Halliday HL. Surfactants: past, present and future. J Perinatol 2008; 28: S47-56.
6. Cummings JJ, Holm BA, Hudak ML, Hudak BB, Ferquson WH, Egan EA. A controlled clinical trial comparison of four different surfactant preparations in surfactant deficient preterm lambs. Am Rev Respir Dis 1992; 145: 999-1004.
7. Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Sys Rev 2001; 2: CD000144.
8. Baroutis G, Kaleyias J, Liarou T, Papathoma E, Hatzistamatiou Z, Costalos C. Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Eur J Pediatr 2003; 162: 476-80.
9. Malloy CA, Nicoski P, Muraskas JK. A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome. Acta Pediatr 2005; 94: 779-84.
10. Ramanathan R, Rasmussen MR, Gerstmann DR, Finer N, Sekar K, North American study group. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol 2004; 21:109-19.
11. Singh N, Hawley KL, Viswanathan K. Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta analysis. Pediatrics 2011; 128: e1588-e1595.
12. Gharehbaghi MM, Sakha HS, Ghojazadeh M, Firoozi F. Complications among premature neonates treated with beractant and poractant alfa. Indian J Pediatr 2010; 77: 751-4.
13. Speer CP, Gefeller O, Groneck P, Laufkotter E, Roll C, Hanssler L, et al. Randomized clinical trials of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 1995; 72: F8-13.
14. Verder H, Agertoft L, Albertsen P, Christensen NC, Curstedt T, Ebesen F, et al. [Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study]. Ugeskr Laeger 1992;154:2136-9.
15. Proquitte H, Dushe T, Hammer H, Rudiger M, Schmalisch G, Wauer RR. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in treatment of respiratory distress syndrome in premature infants. Respir Med 2007; 101: 169-76.
16. Bevilacqua G, Parmiqiani S; OBSERVES Group. An observational study of surfactant treatment in infants of 23-30 weeks, gestation: comparison of prophylaxis and early rescue. J Matern Fetal Neonatal Med 2003; 14: 197-204.
17. Hammoud M, Al-Kazmi N, Alshemmiri M, Talib L, Ranjani VT, Derajan LV, et al. Randomized clinical trial comparing two natural surfactant preparations to treat respiratory distress syndrome. J Matern Fetal Neonatal Med 2004; 15:167-75.
18. Todorov R, Lordanova A, Georgiev GA, Petkova KH, Stoimenova E, Georgieva R, et al. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their therapeutic effectiveness]. AkushGinekol (Sofiia) 2007;46:29-36.
19. Rudiger M, Tolle A, Meier W, Rustow B. Naturally derived commercial surfactants differ in composition of surfactant lipid and in surface viscosity. Am J Physiol Lung Cell Mol Physiol 2005; 288: L379-383.
20. Jobe AH. Pulmonary surfactant therapy. N Eng J Med 1993; 328: 861-8.